PAULA GEORGE: Open Payments
NPI 1346310471 · PLATTSBURGH, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,017 in 48 payments from 15 companies in 2025. Trend: 2023 $1,182 · 2024 $1,051 · 2025 $1,017
Food & beverage: $1,017
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $190 |
| Novo Nordisk Inc | 8 | $163 |
| PFIZER INC. | 6 | $120 |
| Amgen Inc. | 6 | $117 |
| AstraZeneca Pharmaceuticals LP | 5 | $93 |
| Lundbeck LLC | 2 | $66 |
| Lilly USA, LLC | 3 | $57 |
| GlaxoSmithKline, LLC. | 2 | $50 |
| Astellas Pharma US Inc | 1 | $36 |
| Otsuka America Pharmaceutical, Inc. | 1 | $25 |
Products named: Ozempic, UBRELVY, REXULTI, NURTEC ODT, QULIPTA, ELIQUIS, OTEZLA, MOUNJARO.
Industry payments across NY — which companies pay providers there.
